Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-054512

Chief Executive Officer sold 10,240 shares at $0.80 ($8,151)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-03 Sale : show line 1 in the form −10,240 $0.80 $8,151 792,695 D
Open-market sales · 10,240 sh · avg $0.80 · $8,151
Loading xslF345X05/ownership.xml…